Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102301 | 12610230 | 1 | I | 20160721 | 20160801 | 20160801 | EXP | GB-MHRA-MIDB-14367D93-B290-47C0-81DD-598791716A67 | GB-MYLANLABS-2016M1030348 | MYLAN | 0.00 | Y | 0.00000 | 20160801 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102301 | 12610230 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | Y | U | 90763 | ||||||||
| 126102301 | 12610230 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | REDUCED TO 37.5MG. | Y | U | 0 | 75 | MG | QD | |||||
| 126102301 | 12610230 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, BID | Y | U | 0 | 80 | MG | BID | |||||
| 126102301 | 12610230 | 4 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 126102301 | 12610230 | 5 | C | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | Topical | SOAP SUBSTITUTE | U | 0 | |||||||||
| 126102301 | 12610230 | 6 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Topical | U | 0 | 1 | DF | BID | |||||||
| 126102301 | 12610230 | 7 | C | DIPROBASE /01132701/ | 2 | Topical | U | 0 | |||||||||||
| 126102301 | 12610230 | 8 | C | NYSTATIN. | NYSTATIN | 1 | Oral | STRENGTH: 100,000UNITS/ML | U | 0 | 1 | ML | QID | ||||||
| 126102301 | 12610230 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 126102301 | 12610230 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 500MG-1G EVERY 4-6HOURS | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126102301 | 12610230 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126102301 | 12610230 | Acute kidney injury | |
| 126102301 | 12610230 | Chest pain | |
| 126102301 | 12610230 | Diarrhoea | |
| 126102301 | 12610230 | Dyspnoea | |
| 126102301 | 12610230 | Loss of consciousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |